Você procurou por: pasireotid (Dinamarquês - Inglês)

pasireotid
pasireotide

signifor pasireotid
signifor pasireotide

anvendelse med pasireotid
use with pasireotide

aktivt stof: pasireotid.
the active substance is pasireotide.

pasireotid påvirkede ikke insulinfølsomheden.
pasireotide did not affect insulin sensitivity.

pasireotid 0,6 mg to gange dagligt
pasireotide 0.6 mg twice daily

signifor 0,3 mg injektionsvæske, opløsning pasireotid
signifor 0.3 mg solution for injection pasireotide

pasireotid kan sænke ciclosporins relative biotilgængelighed.
pasireotide may decrease the relative bioavailability of ciclosporin.

pasireotid er et cyklohexapeptid, en injicerbar somatostatinanalog.
pasireotide is a cyclohexapeptide, injectable somatostatin analogue.

forventede farmakokinetiske interaktioner, som kan påvirke pasireotid
anticipated pharmacokinetic interactions resulting in effects on pasireotide

pasireotid er et nyt cyklohexapeptid, en injicerbar somatostatinanalog.
pasireotide is a novel cyclohexapeptide, injectable somatostatin analogue.

det er ukendt om pasireotid udskilles i human mælk.
it is unknown whether pasireotide is excreted in human milk.

den anbefalede startdosis er 40 mg pasireotid hver 4. uge.
the recommended initial dose is 40 mg of pasireotide every 4 weeks.

1 hætteglas indeholder 20 mg pasireotid (som pasireotidpamoat).
one vial contains 20 mg pasireotide (as pasireotide pamoate).

signifor er et lægemiddel, der indeholder det aktive stof pasireotid.
signifor is a medicine that contains the active substance pasireotide.

signifor 20 mg pulver og solvens til injektionsvæske, suspension pasireotid
signifor 20 mg powder and solvent for suspension for injection pasireotide

bradykardi er rapporteret ved brug af pasireotid (se pkt 4.8).
bradycardia has been reported with the use of pasireotide (see section 4.8).

en ampul med 1 ml indeholder 0,3 mg pasireotid (som pasireotiddiaspartat).
one ampoule of 1 ml contains 0.3 mg pasireotide (as pasireotide diaspartate).

1 ml injektionsvæske, opløsning indeholder 0,3 mg pasireotid (som pasireotiddiaspartat).
1 ml solution for injection contains 0.3 mg pasireotide (as pasireotide diaspartate).

clearance via nyrerne spiller en mindre rolle i udskillelsen af pasireotid hos mennesker.
renal clearance has a minor contribution to the elimination of pasireotide in humans.